{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042569","form_type":"8-K","ticker":"KAPA","cik":"0001962011","company_name":"Kairos Pharma, LTD.","filed_at":"2026-09-14T20:00:42+00:00","discovered_at":"2026-09-14T20:02:00.324969+00:00","generated_at":"2026-09-14T20:02:11.243459+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Kairos Pharma issues investor presentation; CEO to present at H.C. Wainwright conference","bullets":["Chief Executive Officer John Yu to present at H.C. Wainwright 28th Annual Global Investment Conference in New York, Sept 14-16, 2026.","Presentation provides update on clinical program and activities; published on company website.","No financial, clinical, or guidance figures disclosed in the 8-K filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042569","json":"https://secwatch.observer/filing/0001493152-26-042569.json","markdown":"https://secwatch.observer/filing/0001493152-26-042569.md","text":"https://secwatch.observer/filing/0001493152-26-042569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1962011/000149315226042569/0001493152-26-042569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1962011/000149315226042569/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T20:02:11.243459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}